J0485 Belatacept injection
Also known as: belatacept, Nulojix
Belatacept injection, a selective T-cell costimulation modulator for transplant immunosuppression.
In Plain Language
transplant rejection prevention; immunosuppression medication
Clinical Context
Intravenous selective T-cell costimulation blocker for immunosuppression in renal transplantation. Reduces acute and chronic rejection.
RVU Information
CPT J0485 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J0485?
CPT J0485 (Belatacept injection) is a J Codes (Drugs) code. Belatacept injection, a selective T-cell costimulation modulator for transplant immunosuppression.
How is J0485 administered?
CPT J0485 is administered by a healthcare provider, typically via injection or infusion. Intravenous selective T-cell costimulation blocker for immunosuppression in renal transplantation. Reduces acute and chronic rejection. It is used by Transplantation, Nephrology, Immunology.
When is CPT J0485 used?
Intravenous selective T-cell costimulation blocker for immunosuppression in renal transplantation. Reduces acute and chronic rejection.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.